Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

GENE

Genetic Technologies Ltd. ADR

Jun 21 • 04:00PM ET

1.70

Dollar change +0.05
Percentage change 3.03	%

Healthcare • Diagnostics & Research • Australia • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-28.65	Insider Own	-	Shs Outstand	0.15M	Perf Week	-7.10%
Market Cap	7.50M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-26.72%
Income	-8.44M	PEG	-	EPS next Q	-	Inst Own	1.49%	Short Float	-	Perf Quarter	-32.00%
Sales	5.64M	P/S	1.33	EPS this Y	-	Inst Trans	-57.85%	Short Ratio	2.03	Perf Half Y	-37.92%
Book/sh	0.85	P/B	1.99	EPS next Y	-	ROA	-102.77%	Short Interest	0.13M	Perf Year	-63.83%
Cash/sh	0.58	P/C	2.95	EPS next 5Y	-	ROE	-156.80%	52W Range	1.62 - 4.80	Perf YTD	-29.17%
Dividend Est.	-	P/FCF	-	EPS past 5Y	13.28%	ROI	-252.56%	52W High	-64.58%	Beta	1.15
Dividend TTM	-	Quick Ratio	1.55	Sales past 5Y	1301.35%	Gross Margin	-37.54%	52W Low	5.26%	ATR (14)	0.14
Dividend Ex-Date	-	Current Ratio	1.67	EPS Y/Y TTM	26.17%	Oper. Margin	-114.53%	RSI (14)	34.68	Volatility	6.25% 7.74%
Employees	60	Debt/Eq	0.08	Sales Y/Y TTM	-8.84%	Profit Margin	-149.49%	Recom	1.00	Target Price	6.87
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	95.41%	Payout	-	Rel Volume	0.23	Prev Close	1.65
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-7.17%	Earnings	Feb 23 AMC	Avg Volume	62.17K	Price	1.70
SMA20	-10.47%	SMA50	-24.63%	SMA200	-39.29%	Trades		Volume	14,094	Change	3.03%

Jun-21-24 08:00AM	Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27 (GlobeNewswire)
Jun-18-24 08:00AM	Genetic Technologies Expands Operational Capacity in North America (GlobeNewswire)
Jun-05-24 08:00AM	GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test (GlobeNewswire)
May-29-24 08:00AM	GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer (GlobeNewswire) -12.09%
May-23-24 08:00AM	GeneType and Humanise Health host Know Your Risk Event (GlobeNewswire) -5.63%
08:00AM	Loading…
May-06-24 08:00AM	GTG and 'Wellworks for You' sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees (GlobeNewswire) +5.56%
Apr-30-24 08:00AM	Appendix 4C & Quarterly Business Update March 2024 (GlobeNewswire)
Apr-22-24 03:00PM	Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering (GlobeNewswire)
Apr-18-24 12:17PM	Genetic Technologies Announces $2 Million Registered Direct Offering (GlobeNewswire) -22.78%
Apr-17-24 08:00AM	New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes (GlobeNewswire)
Apr-16-24 08:00AM	GeneType Clinicians' Adoption Growing - Sales up 5-Fold Year on Year (GlobeNewswire)
Apr-12-24 09:00AM	Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Apr-11-24 08:00AM	GTG to pilot GeneType in Breast Screen centers across the U.S. (GlobeNewswire) +8.18%
Apr-08-24 08:00AM	EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch 'Know Your Risk (GlobeNewswire)
Apr-02-24 08:05AM	Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market (GlobeNewswire)
08:00AM	Loading…
Mar-26-24 08:00AM	GTG Global Collaborations and Innovation Update (GlobeNewswire) +5.86%
Mar-25-24 08:00AM	GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare (GlobeNewswire)
Feb-28-24 08:00AM	GTG to launch U.S. Customer Digital Media Sales Campaign (GlobeNewswire)
Jan-31-24 08:00AM	Launching our most comprehensive test and expanding into new global markets (GlobeNewswire)
Jan-05-24 08:00AM	Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Dec-29-23 09:00AM	Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV (ACCESSWIRE)
Dec-14-23 08:00AM	GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness (GlobeNewswire) +13.80%
Dec-12-23 08:00AM	Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change (GlobeNewswire)
Oct-30-23 08:00AM	Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial (GlobeNewswire)
Oct-18-23 08:30AM	GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment (GlobeNewswire) +10.29%
Oct-06-23 09:00AM	Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV (ACCESSWIRE)
Sep-27-23 03:40PM	Genetic Technologies building pathway to profitability (News Direct)
09:00AM	GTG Signs Precision Medicine Pilot with Australia s Largest Private Hospital Network (GlobeNewswire)
Sep-15-23 09:00AM	Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV (ACCESSWIRE)
Sep-12-23 08:00AM	Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release (GlobeNewswire)
08:30AM	Loading…
Sep-11-23 08:30AM	GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner (GlobeNewswire) +5.05%
Sep-01-23 10:00AM	Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV (GlobeNewswire) +5.64%
09:00AM	Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV (ACCESSWIRE)
Aug-30-23 08:45AM	Annual Results Momentum Building on our Commercial Plans (GlobeNewswire)
Aug-09-23 08:00AM	Genetic Technologies Limited Announces Updated Investor Presentation (GlobeNewswire)
Jul-28-23 08:00AM	Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume (GlobeNewswire)
Jul-21-23 08:00AM	Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
May-26-23 03:00PM	Genetic Technologies embraces global vision for genomic-integrated healthcare (News Direct)
May-23-23 08:00AM	GeneType featured on U.S. National TV to raise Breast Cancer Awareness (GlobeNewswire)
Apr-28-23 08:00AM	New Publication Validates geneType for Melanoma Risk Assessment (GlobeNewswire)
Apr-27-23 08:00AM	Quarterly Business Update March 2023 (GlobeNewswire)
Apr-19-23 08:00AM	Publication Validates geneType Prostate Cancer Risk Test (GlobeNewswire)
Mar-27-23 08:00AM	GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation (GlobeNewswire) +6.36%
Mar-13-23 08:00AM	Back-to-back Studies Validate geneType Breast Cancer Risk Test (GlobeNewswire)
Feb-09-23 08:00AM	New Publication Highlights geneTypes Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification (GlobeNewswire) +21.23%
Feb-07-23 10:00AM	Genetic Technologies Announces Closing of $5 Million Registered Direct Offering (GlobeNewswire) -7.91%
Feb-06-23 08:00AM	Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer (GlobeNewswire)
Feb-03-23 08:35AM	Genetic Technologies Announces $5 Million Registered Direct Offering (GlobeNewswire) +80.20%
08:00AM	GENE to Launch Worlds First Comprehensive Risk Test for Breast & Ovarian Cancer (GlobeNewswire)
07:52AM	Why Genetic Technologies Shares Are Skyrocketing During Premarket Session (Benzinga)
Feb-01-23 02:22PM	Genetic Technologies Shares Jump After Strategic Alliance With Qiagen (Benzinga) +13.19%
08:00AM	GTG to form Strategic Alliance with global testing leader QIAGEN (GlobeNewswire)
Jan-30-23 08:00AM	Quarterly Business Update December 2022; Sixth Consecutive Quarter of Growth (GlobeNewswire) -7.26%
Jan-24-23 08:00AM	Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium (GlobeNewswire)
Jan-11-23 08:00AM	Genetic Technologies Provides Business Update (GlobeNewswire)
Dec-06-22 08:00AM	GeneType published in PLOS ONE development of polygenic risk scores for cardiovascular diseases and type 2 diabetes (GlobeNewswire)
Nov-10-22 08:00AM	Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease (GlobeNewswire)
Nov-09-22 08:00AM	Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention (GlobeNewswire)
Oct-25-22 09:14AM	Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details (GlobeNewswire)
Oct-13-22 08:00AM	Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Sep-29-22 08:00AM	Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer (GlobeNewswire)
Sep-02-22 08:00AM	Genetic Technologies Provides Update on US Operations and Payer Engagement (GlobeNewswire)
Aug-30-22 08:00AM	GENE Momentum building - a year in review (GlobeNewswire)
Jul-28-22 08:00AM	Gene achieves key milestones and growth (GlobeNewswire)
Jul-18-22 08:00AM	GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians (GlobeNewswire)
Jul-14-22 08:00AM	Completion of AffinityDNA Acquisition expanding global direct-to-consumer business (GlobeNewswire) +7.58%
Jul-05-22 08:00AM	EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage (GlobeNewswire) +5.79%
Jul-01-22 08:00AM	GeneType Risk Assessment Test onboarding in 16 clinics (GlobeNewswire)
Jun-16-22 08:00AM	Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test (GlobeNewswire)
May-16-22 09:00AM	Acquisition of global direct to consumer ecommerce business (GlobeNewswire)
Apr-08-22 08:00AM	Genetic Technologies drives leadership in precision medicine with Multi-Risk Test (GlobeNewswire)
Feb-23-22 08:00AM	US Patent Office Grants Patent for COVID-19 Risk Test (GlobeNewswire)
Feb-22-22 08:00AM	GeneType Multi-Test Receives Regulatory Approval for Commercial Release in USA and Australia (GlobeNewswire)
Jan-19-22 09:00AM	Genetic Technologies Reports Q2 FY22 Cash Flow Results (GlobeNewswire) +5.64%
Dec-21-21 08:00AM	Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GENE, geneType), a global leader in genomics-based tests in health, wellness and serious disease provides the following business update: (GlobeNewswire)
Dec-10-21 07:30AM	GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium (GlobeNewswire)
Dec-09-21 07:30AM	Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO (GlobeNewswire) -5.79%
Oct-25-21 08:30AM	Genetic Technologies Reports Q1 FY22 Results (GlobeNewswire)
Oct-04-21 08:00AM	GENE Delivers Material 12-Fold Increase in Revenue in the Quarter Ended September 2021 (GlobeNewswire)
Sep-30-21 09:00AM	Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report® (GlobeNewswire)
Sep-28-21 08:04AM	GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity (GlobeNewswire)
Sep-09-21 09:00AM	BelHealth Completes Asset Sale of General Genetics Corp. (PR Newswire)
Aug-31-21 09:00AM	Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy (GlobeNewswire)
Aug-16-21 08:00AM	Genetic Technologies Enters Multi-Billion-Dollar Consumer Genomics Market (GlobeNewswire)
Jul-26-21 08:25AM	Genetic Technologies Rapidly Accelerating Commercialization Plans (GlobeNewswire)
Jul-19-21 09:27AM	Genetic Technologies Acquires EasyDNA To Expand Into Wellness Testing (Benzinga)
08:00AM	Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA (GlobeNewswire)
Jul-09-21 08:00AM	Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities (GlobeNewswire)
Jun-11-21 08:00AM	US Patent Office Grants Foundational Pharmacogenomic Patent (GlobeNewswire) +9.13%
Jun-01-21 08:00AM	Genetic Technologies COVID-19 Risk Test Now Available in US through Partnership with Infinity BiologiX (GlobeNewswire) -6.57%
May-13-21 09:01AM	Genetic Technologies Interview to Air on Bloomberg Television U.S. on the RedChip Money Report® (GlobeNewswire)
Apr-26-21 08:00AM	Genetic Technologies COVID-19 Risk Test Approved for Commercial Release (GlobeNewswire)
Apr-12-21 09:37AM	Company News for Apr 12, 2021 (Zacks) -7.88%
08:15AM	Genetic Technologies appoints Mike Tonroe as CFO (GlobeNewswire)
Apr-09-21 11:15AM	Genetic Technologies Provides Update on COVID-19 Risk Test Launch (GlobeNewswire) +6.53%
Mar-04-21 07:00AM	Genetic Technologies Signs Multi-Year US Distribution Agreement for COVID Risk Test (GlobeNewswire) -8.17%
Feb-26-21 09:20AM	Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report® (GlobeNewswire)
Jan-25-21 04:00PM	Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering (GlobeNewswire) -5.53%
Jan-21-21 11:30AM	Genetic Technologies Announces $6.56 Million Registered Direct Offering (GlobeNewswire) +27.44%
07:00AM	Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing (GlobeNewswire)

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through ,the EasyDNA, AffinityDNA, and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GENE

Genetic Technologies Ltd. ADR

Upgrade your FINVIZ experience